Interroll (INRN) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
12 Mar, 2026Executive summary
Order intake increased by 5% to CHF 545.3 million (+9.2% in local currency), with strong acceleration in H2 2025, especially in China and e-commerce sectors.
2025 marked a transition year with restructuring, strategic refocus, and cultural transformation, emphasizing innovation, market focus, and expansion into high-growth sectors.
Expanded global footprint with 16 factories and localized R&D, enabling resilience against macroeconomic and geopolitical challenges.
Enhanced customer focus, innovation, and operational efficiency, including new R&D hub in China and acquisition of Sortteq.
E-commerce and airport end markets showed recovery, while industrial manufacturing and automotive remained weak.
Financial highlights
Order intake reached CHF 545.3 million (+5% in CHF, +9.2% in local currency), with a 12% surge in H2 and broad-based growth across regions and product groups.
Sales declined 2.5% to CHF 514.2 million, but rose 1.4% in local currency; EMEA grew 1.4%, Americas fell 9.8%, APAC dropped 3.5%.
EBITDA was CHF 94.1 million (18.3% margin), EBIT CHF 71.8 million (14.0% margin), both down year-over-year.
Net result was CHF 55.9 million (10.9% margin), impacted by FX losses and lower interest income.
Operating cash flow dropped 41.2% to CHF 54.1 million; free cash flow down 47.9% to CHF 40.3 million.
Outlook and guidance
Market stabilization broadened in 2025, with optimistic customer feedback and growing project demand.
Expectation of sales rebound in 2026, driven by strong order intake and backlog, especially in Americas.
Continued investment in innovation and market access, with cost discipline maintained.
FX headwinds expected to persist in 2026, with local currency sales growth anticipated.
No specific quantitative guidance provided, but positive momentum in order pipeline and margin leverage expected.
Latest events from Interroll
- EBIT, EBITDA, and net result rose despite lower sales, with EMEA leading recovery.INRN
H1 20242 Feb 2026 - Order intake steady, sales down, robust margins; dividend unchanged, 2025 a transition year.INRN
H2 20241 Dec 2025 - Stable sales and order intake, with margin pressure but strong project and regional momentum.INRN
H1 202531 Jul 2025